NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
OnEMI Technology Solutions Limited (Kissht) announced that its Assets Under Management (AUM) crossed the ₹10,000 crore milestone, driven by its digital lending platform and expanding Loan Against Property portfolio. The company highlighted that its capital position was recently strengthened by a ₹832.2 crore preferential issue in October 2026, representing approximately 32.6% of its ₹2,556 crore market cap. The lending franchise currently serves over 12.80 million cumulative customers backed by 45+ lending and co-lending partners. Kissht operates through its NBFC-Middle Layer subsidiary, Si Creva Capital Services Private Limited.
உச்சம் நம்பிக்கை
என்ன மாறியதுKissht officially crossed ₹10,000 crore in total AUM, marking a key operational scale milestone.
ஏன் இது முக்கியம்Reaching ₹10,000 crore AUM expands operational leverage and validates the scale of its digital lending platform following the recent ₹832.2 crore equity infusion.
📅 குறுகிய காலம்Positive sentiment driver highlighting strong business traction and deployment of recently raised capital.
📈 நீண்ட காலம்Demonstrates rapid execution in scaling the credit book; long-term value will depend on maintaining credit underwriting standards and managing NPAs during unsecured and secured book growth.
⚠ அபாய எச்சரிக்கைகள்
Credit risk and delinquency rates inherent to high-growth unsecured personal loan portfolios
Dilution impact from the recent ₹832.2 crore preferential equity issuance
👀 கவனிக்க வேண்டியவை
Track the upcoming quarterly earnings for asset quality trends (NPA levels) and credit costs as the AUM scales, alongside progress on the secured Loan Against Property mix.
Sellowrap Q2 Standalone Revenue Up 56% to Rs 68.33 Cr; Net Profit Drops 60% to Rs 0.98 Cr
Sellowrap Industries reported its Q2 (ended Sep 30, 2026) standalone revenue from operations at Rs 68.33 crore, up 56.4% YoY from Rs 43.69 crore in Q2 FY26. However, standalone net profit for the quarter declined by 59.9% YoY to Rs 0.98 crore compared to Rs 2.45 crore, impacted by higher material consumption and operating costs. For H1 (half-year ended Sep 30, 2026), revenue stood at Rs 128.19 crore with a net profit of Rs 3.02 crore. Additionally, the company reported unutilised IPO proceeds of Rs 1.19 crore out of the Rs 25.98 crore net proceeds, held in fixed deposits.
உச்சம் நம்பிக்கை
என்ன மாறியதுSellowrap released its financial results for Q2 and H1 ended September 30, 2026, alongside an IPO proceeds utilization certificate.
ஏன் இது முக்கியம்While top-line expansion remains robust with revenue scaling to Rs 68.33 crore, profitability contracted sharply due to escalating input and operational costs.
📅 குறுகிய காலம்The market may react negatively to the sharp drop in net profit despite strong topline revenue growth.
📈 நீண்ட காலம்Long-term performance hinges on stabilizing operating margins and converting high top-line growth into positive operating cash flows.
⚠ அபாய எச்சரிக்கைகள்
Severe margin compression driven by rising material costs
Negative operating cash flows of Rs 9.30 crore in H1
👀 கவனிக்க வேண்டியவை
Track margin recovery and raw material cost trends in the upcoming quarters, as well as the complete deployment of the remaining Rs 1.19 crore IPO capex funds.
Sanathan Textiles Q2 FY27 Standalone Revenue up 29.3% to ₹992 Cr; Reappoints Key Directors
Sanathan Textiles reported standalone revenue of ₹992.11 crore for the quarter ended September 30, 2026, marking a 29.3% YoY growth compared to ₹767.09 crore in the corresponding period of the previous year. Net profit for the standalone entity reached ₹68.69 crore for Q2 FY27, up 13.3% YoY from ₹60.64 crore, supported by stronger total operational throughput. Half-year standalone net profit stood at ₹123.64 crore against ₹97.80 crore in H1 FY26. Concurrently, the Board approved the re-appointment of promoter directors Paresh Dattani (CMD), Ajaykumar Dattani (JMD), and Anilkumar Dattani (ED) for five-year tenures starting December 1, 2026, subject to shareholder approval.
உச்சம் நம்பிக்கை
என்ன மாறியதுBoard approved Q2 FY27 unaudited standalone/consolidated financial results and approved a 5-year extension of key executive promoter director roles from December 1, 2026.
ஏன் இது முக்கியம்Revenue acceleration reflects expanded capacity coming online, though rising finance costs continue to demand monitoring given leverage levels.
📅 குறுகிய காலம்The market will digest the quarterly earnings growth against current high valuations (TTM P/E ~74.8x).
📈 நீண்ட காலம்Performance will hinge on the successful ramp-up of new capacity toward the FY27 revenue target of ₹6,000 Cr and the trajectory of operating margins.
👀 கவனிக்க வேண்டியவை
Monitor consolidated figures and management commentary regarding the utilization ramp-up of the 700 MT/day Punjab expansion facility, along with debt servicing capabilities given elevated finance costs.
Suzlon Q2 FY27 Call: Deliveries Up 40% QoQ to 710 MW, 6 GW Order Book Backlog
Suzlon Energy released its Q2 FY27 earnings call transcript highlighting record Q2 deliveries of 710 MW (up 40% QoQ) and commissioning growth of 69% to 454 MW. Q2 FY27 consolidated revenue reached INR 4,869 crore (up 27% QoQ) with EBITDA at INR 720 crore and PAT at INR 394 crore. WTG contribution margins compressed YoY from 26.9% to 21.2% due to customer mix and commodity fluctuations. The company holds a robust 6 GW order book offering 18 months of execution visibility, supported by a net cash position of INR 2,048 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the detailed Q2 FY27 earnings conference call transcript following the quarterly results.
ஏன் இது முக்கியம்Confirms strong volume momentum (710 MW delivered) and strong order backlog (6 GW), but highlights WTG margin compression down to 21.2%.
📅 குறுகிய காலம்Market focus will center on managing WTG contribution margins and working capital expansion ahead of the busier H2 execution cycle.
📈 நீண்ட காலம்A 6 GW order book, operational 4.5 GW capacity, and zero net debt provide structural stability as India scales up to annual multi-gigawatt wind additions.
⚠ அபாய எச்சரிக்கைகள்
WTG contribution margin compression due to scope mix, forex, and commodity headwinds
Execution delays in grid connectivity or commissioning of erected turbines
👀 கவனிக்க வேண்டியவை
Monitor execution run-rates toward the ~1,300 MW erected turbine commissioning pipeline and track margin recovery in WTG deliveries across upcoming quarters.
Sheetal Universal Seeks Shareholder Approval to Migrate from NSE Emerge to Main Board
Sheetal Universal Limited has issued a Postal Ballot notice seeking shareholder approval via special resolution to migrate its equity shares from the NSE SME Emerge platform to the Main Board of NSE. The company has been listed on the SME platform since December 11, 2023, and will complete the mandatory 3-year listing requirement on December 11, 2026. Per SEBI ICDR regulations, migration requires non-promoter votes in favor to be at least twice the votes cast against. Remote e-voting is scheduled from November 13, 2026, to December 12, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுSheetal Universal has formally initiated shareholder voting to migrate its listing from the NSE SME platform to the NSE Main Board.
ஏன் இது முக்கியம்Migration to the Main Board removes SME lot-size constraints, expanding retail and institutional participation, improving trading liquidity, and aiding visibility for a Rs 443 Cr market-cap firm.
Paid-up equity share capital: Rs. 12,87,59,990Total equity shares: 1,28,75,999Listing anniversary date (3 years): டிசம்பர் 11, 2026E-voting window: நவம்பர் 13, 2026 to டிசம்பர் 12, 2026
📅 குறுகிய காலம்Near-term focus will be on achieving the required non-promoter shareholder approval threshold via the postal ballot concluding on December 12, 2026.
📈 நீண்ட காலம்Main Board listing structurally improves trading volume, eliminates lot-size illiquidity, and facilitates broader institutional ownership as the company scales its processed agricultural business.
⚠ அபாய எச்சரிக்கைகள்
Requires non-promoter approval by at least 2:1 margin under SEBI ICDR Regulation 277
Final migration remains subject to NSE meeting eligibility criteria and regulatory approvals
👀 கவனிக்க வேண்டியவை
Track the e-voting results expected within two working days after December 12, 2026, and subsequent NSE in-principle approval once the 3-year SME tenure completes on December 11, 2026.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
TVS Motor Q2 PAT Up 52% to ₹1,377 Cr; Board Approves Demerger of Consumer Finance Business
TVS Motor reported record Q2 performance, with revenue growing 44% YoY to ₹17,103 crore and PAT rising 52% YoY to ₹1,377 crore. Total sales volume increased 27% to 1.9 million units, supported by 129% domestic EV sales growth. In a key strategic move, the Board approved the demerger of its consumer finance and related businesses (TVS Credit Services) with an appointed date of July 2027. Shareholders will receive shares in the new entity in a 1:1 ratio alongside TVS Motor shares.
உச்சம் நம்பிக்கை
என்ன மாறியதுTVS Motor released its Q2 earnings call transcript detailing record quarterly financials and formalizing the strategic demerger of its consumer finance business.
ஏன் இது முக்கியம்The demerger unlocks shareholder value by separating capital-intensive financial services (TVS Credit) from the core automotive business, allowing focused capital allocation for both entities.
Q2 வருவாய்: ₹17,103 கோடிQ2 Profit After Tax: ₹1,377 கோடிQ2 EBITDA Margin: 13.0%Q2 Sales Volume: 1.9 million unitsPlanned TVS Credit Capital Infusion: ₹1,200 கோடி
📅 குறுகிய காலம்Strong festive tailwinds, outperforming domestic EV volume growth, and market share expansion across ICE 2-wheelers and 3-wheelers provide positive operational momentum.
📈 நீண்ட காலம்The demerger of TVS Credit Services creates a standalone consumer finance player and sharpens TVS Motor's return profile, reducing drag from financing subsidiary capitalization.
⚠ அபாய எச்சரிக்கைகள்
Regulatory approval timelines for NBFC consolidation and subsequent demerger
Ongoing drag and cash requirement from loss-making global operations (e.g., Norton)
👀 கவனிக்க வேண்டியவை
Track statutory and regulatory approvals for the TVS Credit NBFC consolidation (expected by March-April 2027) followed by the demerger execution scheduled around July 2027.
Sumeet Industries Revises Q2 FY27 Results to Add ₹1.65 Cr Tax; Q2 Revenue Up 35% YoY to ₹364 Cr
Sumeet Industries submitted a revised integrated filing for Q2 and H1 FY27 to correct a typographical oversight where a tax provision of ₹165.31 lakhs (₹1.65 crore) was omitted from the consolidated column. For Q2 FY27 (quarter ended Sep 30, 2026), consolidated revenue from operations rose 35.2% YoY to ₹364.18 crore compared to ₹269.30 crore in Q2 FY26. Consolidated net profit after tax and share of profit from associates stood at ₹4.40 crore, down 55.3% YoY from ₹9.86 crore, impacted by lower operating margins and higher material expenses. The filing also detailed the deviation in the utilization of ₹199.75 crore gross proceeds raised via a Rights Issue, reallocating funds initially intended for solar and loan prepayment toward operationalizing Nakoda's chips plant through subsidiary SSCL.
உச்சம் நம்பிக்கை
என்ன மாறியதுCorrection of a typographical error in the Q2 FY27 consolidated earnings to include a ₹165.31 lakh tax provision, alongside disclosure of reallocations in Rights Issue fund utilization.
ஏன் இது முக்கியம்Clarifies actual consolidated net profitability post-tax and formally discloses that solar project capex of ₹22 crore and debt prepayment of ₹14 crore were diverted to acquire and operationalize the Nakoda chips plant.
Tax provision corrected: ₹165.31 லட்சம்Q2 FY27 Revenue from Operations: ₹36417.64 லட்சம்Q2 FY27 PAT and Associate Profit: ₹440.17 லட்சம்Rights Issue Gross Proceeds: ₹19975.11 லட்சம்Rights Issue vs Market Cap: ~30.8%
📅 குறுகிய காலம்Neutral as the clerical amendment does not alter standalone operational numbers, though margins continue to remain compressed relative to prior year levels.
📈 நீண்ட காலம்Structural improvement hinges on whether the redeployed Rights Issue proceeds into the Nakoda chips plant generate targeted revenue and if power cost reductions are achieved.
⚠ அபாய எச்சரிக்கைகள்
Deviation from stated Rights Issue objectives, deferring solar capex and loan prepayments.
Significant YoY decline in quarterly net profit despite top-line growth.
👀 கவனிக்க வேண்டியவை
Track the operationalization and margin contribution of the acquired Nakoda chips plant under subsidiary SSCL, along with progress on the company's planned 14 MW solar capacity.
Best Agrolife Q2 PAT Up 46% to Rs 57 Cr Despite Revenue Declining 21% to Rs 407 Cr
Best Agrolife reported Q2 FY27 earnings call transcripts, posting revenue of Rs 407 crore, down 21.3% YoY from Rs 517 crore due to delayed and uneven monsoons impacting Kharif crop sowing. Despite top-line contraction, Q2 EBITDA expanded to Rs 101 crore compared to Rs 78 crore in Q2 FY26, and PAT rose 46% YoY to Rs 57 crore, driven by a higher share of margin-accretive patented products. For H1 FY27, revenue reached Rs 803 crore while PAT improved to Rs 98 crore against Rs 59 crore last year. Management noted balance sheet stress from slow-moving inventory due to technical delays, expecting inventory normalization by March.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the transcript for the Q2 and H1 FY27 earnings conference call held on November 2, 2026.
ஏன் இது முக்கியம்Clarifies management's shift from generic volumes to margin-rich patented molecules, while highlighting operational delays in commercializing specialized formulations and balance sheet leverage risks.
📅 குறுகிய காலம்Market sentiment may remain cautious regarding balance sheet tightness and seasonal sales return risks despite improved Q2 profitability margins.
📈 நீண்ட காலம்Structural transformation hinges on international registrations and sustaining higher gross margins from patented molecules (target 30-35% EBITDA) versus commoditized generics.
⚠ அபாய எச்சரிக்கைகள்
Working capital pressure and stretched balance sheet requiring inventory liquidation by March
Revenue volatility caused by uneven rainfall and agroclimatic seasonality
Historically elevated product sales returns during Q3
👀 கவனிக்க வேண்டியவை
Track working capital levels and inventory reduction timelines leading up to March, alongside Q3 sales returns which have historically pressured winter revenue.
Q2 FY27 Results: Standalone Net Profit Up 424% YoY to ₹12.00 Cr, Operating Revenue at ₹34.57 Cr
63 moons technologies reported standalone revenue from operations of ₹34.57 Cr for Q2 FY27 (ended September 30, 2026), jumping 132% YoY from ₹14.92 Cr in Q2 FY26. Standalone net profit stood at ₹12.00 Cr, up significantly from ₹2.29 Cr in the prior-year period, despite an exceptional hit of ₹15.00 Cr from write-offs in subsidiary investments. Other income of ₹46.18 Cr continued to outstrip operating revenue, driven primarily by ₹40.55 Cr in interest income. Meanwhile, subsidiary-level performance weighed on the group, with reviewed domestic subsidiaries reporting an aggregate quarterly loss of ₹114.61 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியது63 moons released its Q2 FY27 financial results showing a rise in standalone operating top-line and bottom-line alongside ongoing subsidiary write-offs.
ஏன் இது முக்கியம்Operating revenue has grown YoY but earnings remain heavily reliant on treasury/interest income rather than core software margins, while subsidiary losses continue to impact group health.
Standalone Revenue from Operations (Q2 FY27): ₹3,456.56 லட்சம்Standalone Net Profit (Q2 FY27): ₹1,200.28 லட்சம்Other Income (Q2 FY27): ₹4,617.58 லட்சம்Exceptional Items: ₹(1,500.00) LakhsReviewed Domestic Subsidiaries Net Loss: ₹(11,460.50) Lakhs
📅 குறுகிய காலம்Markets will digest standalone operational growth against the significant losses reported across key domestic subsidiaries.
📈 நீண்ட காலம்Structural recovery depends on monetization of new ventures in Blockchain/Cybersecurity and resolution of ongoing regulatory and legal attachments under the MPID Act.
⚠ அபாய எச்சரிக்கைகள்
Substantial ongoing losses in subsidiaries (₹114.61 Cr loss in reviewed domestic entities)
Earnings quality relies heavily on treasury interest income rather than core operations
Continued provisions/write-offs on subsidiary investments (₹15.00 Cr in Q2)
👀 கவனிக்க வேண்டியவை
Track the full consolidated earnings outcome and performance of subsidiaries (especially Ticker Ltd and 63SATS), alongside any updates on NSEL/MPID legal attachments restricting company cash.
Tempsens Instruments Approves Q2 Results, Appoints Executive Director and Joint Auditor
Tempsens Instruments approved its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board also appointed Mr. Aryan Rathi as Executive Director cum Lead-Global Sales for 5 years effective October 30, 2026, while Non-Executive Director Mr. Ankit Talesra resigned. Additionally, M/s P C MODI & CO was appointed as Joint Statutory Auditor, and the ESOP 2025 scheme covering up to 16,13,320 options was approved for shareholder ratification via postal ballot.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Board approved Q2 FY27 results, restructured board seats with one appointment and one resignation, and initiated shareholder voting for a joint statutory auditor and ESOP ratification.
ஏன் இது முக்கியம்Broadens leadership in global sales and enhances statutory oversight with a joint auditor, alongside aligning employee incentives via the pre-IPO ESOP scheme ratification.
Total ESOP pool shares: 16,13,320ESOP options granted to date: 3,47,100ESOP options available for grant: 12,52,676Subsidiaries H1 revenue reviewed: ₹ 616.77 million
📅 குறுகிய காலம்Neutral trading expected as board transitions and auditor additions are routine governance matters.
📈 நீண்ட காலம்Strengthened focus on global sales via executive appointment could aid international distribution.
⚠ அபாய எச்சரிக்கைகள்
Potential equity dilution from the exercise of up to 16,13,320 ESOP shares
👀 கவனிக்க வேண்டியவை
Track the upcoming postal ballot voting results for the approval of the director appointment, joint auditor, and ESOP 2025 ratification.
Q2 FY27 PAT Drops 75% YoY to ₹21 Cr Despite 6% Revenue Growth; Targets 25.1 MTPA by FY30
JK Lakshmi Cement released its Q2 FY27 investor presentation, reporting a 75% YoY decline in net profit to ₹21 crore compared to ₹82 crore in Q2 FY26. Net sales grew 6% YoY to ₹1,617 crore, but profitability contracted sharply due to fuel costs rising to ₹1.82/K.Cal and EBITDA per tonne dropping 29% YoY to ₹517/ton. Net debt increased to ₹2,027 crore from ₹1,266 crore in March 2026, pushing Net Debt/EBITDA up to 2.31x. The company maintains its long-term roadmap to expand grey cement capacity from 18.0 MTPA to 25.1 MTPA by FY30.
உச்சம் நம்பிக்கை
என்ன மாறியதுJK Lakshmi Cement published its Q2 FY27 operational and financial performance deck, highlighting sharp margin compression and ongoing progress on expansion capex.
ஏன் இது முக்கியம்Higher fuel costs and lower realizations compressed operating margins, with EBITDA/ton falling well below the company's stated ₹1,200/ton target, increasing net leverage to 2.31x EBITDA.
Q2 FY27 Net Sales: ₹1,617 கோடிQ2 FY27 PAT: ₹21 கோடிEBITDA per tonne: ₹517Net Debt (30 Sep 2026): ₹2,027 கோடிTarget Capacity by FY30: 25.1 MTPA
📅 குறுகிய காலம்Margin pressure is likely to weigh on sentiment as EBITDA/ton at ₹517 fell 29% YoY amid rising energy costs (₹1.82/K.Cal).
📈 நீண்ட காலம்Capacity expansion from 18 MTPA to 25.1 MTPA by FY30 and green power adoption (targeting 60% by FY30) provide a structural volume and efficiency runway if leverage is kept in check.
⚠ அபாய எச்சரிக்கைகள்
Sharp rise in fuel costs to ₹1.82/K.Cal from ₹1.54/K.Cal in Q2 FY26
Net Debt/EBITDA deterioration from 1.12x in March 2026 to 2.31x in September 2026
Lower capacity utilization of 62% in Q2 FY27
👀 கவனிக்க வேண்டியவை
Monitor fuel cost trends and pricing realization in Northern and Eastern markets, alongside progress on the Durg Line II and Madhubani capacity additions.
Go Fashion Q2 FY27 Earnings Call: Q2 Revenue Down 3% YoY to ₹218 Cr, SSSG Flat
Go Fashion reported Q2 FY27 revenue of ₹218 crore, declining 3% YoY due to a delayed festive season shifting dispatches into October. Gross margins softened to 60.8% impacted by higher fabric costs, while PAT stood at ₹9 crore after an exceptional capex write-off of ₹3.4 crore for store closures. For H1 FY27, revenue reached ₹440 crore (down 1.5% YoY) with an EBITDA margin of 28.0% and an exceptional write-off of ₹9.9 crore. The company closed 89 smaller stores and opened 24 larger stores in H1, raising total retail space to ~4.4 lakh sq. ft. across 737 EBOs.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the formal transcript for the Q2 FY27 analyst call detailing store consolidation, raw material cost pressures, and festive timing shifts.
ஏன் இது முக்கியம்Provides granularity on why revenue contracted, outlines store closure capex write-offs (₹9.9 cr in H1), and confirms the strategic pivot toward larger-format company-owned stores to double square footage over five years.
📅 குறுகிய காலம்Subdued Q2 performance was telegraphed; near-term focus will be on October festive channel dispatches and SSSG prints.
📈 நீண்ட காலம்Transition to larger EBO formats (averaging 608 sq. ft.) and dailywear expansion aim to improve store-level economics, though near-term margins remain pressured by raw material inflation.
⚠ அபாய எச்சரிக்கைகள்
Continued fabric price inflation squeezing gross margins
Elevated capex write-offs from shutting underperforming small-format stores
Sluggish SSSG recovery in an environment of muted apparel consumption
👀 கவனிக்க வேண்டியவை
Track Q3 FY27 festive recovery in Same Store Sales Growth (SSSG) and monitor whether calibrated price hikes successfully offset raw material inflation without hurting consumer volumes.
Engineers India Q2 Concall: Order Book Hits Record ₹20,421 Cr; H1 Inflows Reach ₹7,428 Cr
Engineers India Limited released its Q2 earnings conference call transcript, highlighting an all-time high order book of ₹20,421 crore as of September 30, 2026 (up from ₹14,424 crore in June 2026). Order inflows for H1 stood at ₹7,428 crore, with total inflows reaching around ₹8,100 crore till date. Q2 standalone turnover was ₹802 crore with PAT rising 65% QoQ to ₹180 crore, driven by a higher revenue share from the high-margin consultancy segment (68% vs 32% turnkey). Management guided for at least ₹8,000 crore or more in fresh order inflows for the next financial year.
உச்சம் நம்பிக்கை
என்ன மாறியதுSubmission of the formal transcript of the Q2 FY27 post-earnings conference call held on October 30, 2026.
ஏன் இது முக்கியம்Confirms substantial order book expansion to ~5.3x TTM revenue (₹3,877 Cr), providing multi-year revenue visibility, and demonstrates margin expansion from a structural shift toward high-margin consultancy projects.
Order book (Sep 30, 2026): ₹20,421 கோடிOrder book vs TTM revenue: ~527%H1 Order inflows: ₹7,428 கோடிQ2 Standalone PAT: ₹180 கோடிQ2 EBITDA margin: 27%
📅 குறுகிய காலம்Transcript details are broadly priced in following the earnings release, but qualitative commentary on pipeline execution and consultancy sustainability supports near-term sentiment.
📈 நீண்ட காலம்A record order book of over ₹20,400 crore alongside diversification into data centers and international consulting provides strong revenue visibility for the next 3-4 years.
⚠ அபாய எச்சரிக்கைகள்
Slowdown or delays in major domestic hydrocarbon capex decisions
Long bidding and decision cycles for large overseas projects in the Middle East and Africa
👀 கவனிக்க வேண்டியவை
Track conversion of the record order book into quarterly billings and monitor whether the consultancy mix remains near current elevated levels (~68%) to sustain operating margins.
Somany Ceramics Declares ₹6/Share Interim Dividend; Ups Sanitaryware Arm Stake to 76%
Somany Ceramics' Board approved an interim dividend of ₹6 per equity share (300% on ₹2 face value) for FY27, with the record date set for November 13, 2026. Additionally, the Board approved acquiring up to an additional 25% stake (24,75,000 shares) in subsidiary Somany Sanitary Ware Private Limited (SSWPL), increasing its holding from 51% to up to 76%. SSWPL reported FY26 turnover of ₹49.82 Cr, and the cash acquisition is slated for completion within 120 days. An exceptional expense of ₹2.37 Cr (₹237 lakhs) was also recognized in Q2 under a dues recovery settlement scheme.
உச்சம் நம்பிக்கை
என்ன மாறியதுBoard approved a ₹6/share interim dividend and greenlit the purchase of up to an additional 25% stake in its sanitaryware subsidiary to raise ownership to 76%.
ஏன் இது முக்கியம்Higher ownership in SSWPL aligns with the company's stated strategic goal to expand bathware and sanitaryware's share in overall revenue to 15-16%, while the dividend provides direct cash payout to shareholders.
Interim Dividend per share: Rs. 6/-Dividend Record Date: 13th நவம்பர், 2026SSWPL Stake Increase: 51% to up to 76%SSWPL FY26 Turnover: Rs. 4,981.82 LakhsExceptional Settlement Expense: Rs. 237 lakhs
📅 குறுகிய காலம்Share price will adjust for the ₹6 dividend post-record date (Nov 13, 2026); sentiment supported by healthy payout and consolidation of sanitaryware business.
📈 நீண்ட காலம்Increasing control in sanitaryware aids margin and mix diversification, strengthening the group's positioning beyond core ceramic tiles.
⚠ அபாய எச்சரிக்கைகள்
Acquisition price/cost of acquisition for the 25% SSWPL stake is not yet disclosed.
👀 கவனிக்க வேண்டியவை
Track the ex-dividend date prior to the November 13, 2026 record date, and watch for final cash consideration details for the SSWPL stake increase over the 120-day timeline.
Q2 PAT Drops 75% YoY to ₹20.88 Cr; Ongoing ₹3,000 Cr Durg Capex on Track
JK Lakshmi Cement reported standalone Net Sales of ₹1,616.92 crore for Q2 FY27 (ended September 30, 2026), up 5.6% YoY from ₹1,531.77 crore. However, operating profitability came under severe pressure, with PBIDT falling 29.4% YoY to ₹164.49 crore and PAT dropping 74.6% YoY to ₹20.88 crore. Net Debt to EBITDA increased significantly to 2.31x from 1.25x in the year-ago period. On the expansion front, the company reiterated its ₹3,000 crore Durg capex (4.6 MTPA cement capacity) targeted for completion by March 2028.
உச்சம் நம்பிக்கை
என்ன மாறியதுJK Lakshmi Cement declared its Q2 and H1 FY27 financial results showing volume growth but sharp margin compression, alongside updates on ongoing capex projects.
ஏன் இது முக்கியம்Elevated petcoke and input costs coupled with intense regional competition severely curtailed earnings, pushing Net Debt/EBITDA up to 2.31x while execution on a massive ₹3,000 crore capex is ongoing.
Q2 Net Profit: ₹20.88 கோடிQ2 Net Sales: ₹1616.92 கோடிQ2 PBIDT: ₹164.49 கோடிDurg Capex Cost: ₹3000 கோடிDurg Capex vs Net Worth: ~76.3%
📅 குறுகிய காலம்Margin contraction and rising leverage metrics are likely to weigh on sentiment, although H2 typically brings peak construction season demand.
📈 நீண்ட காலம்Long-term trajectory depends on timely execution of the ₹3,000 crore Durg expansion by March 2028, which aims to expand total capacity to ~25 MTPA by FY30.
⚠ அபாய எச்சரிக்கைகள்
High leverage: Net Debt to EBITDA expanded from 1.25x to 2.31x YoY
Input cost inflation: High petcoke, freight, and packaging costs compressing PBIDT
Inability to pass through cost increases due to intense regional competition
👀 கவனிக்க வேண்டியவை
Track cement price realization trends and fuel cost pressures in North/East markets in H2, along with debt levels as the ₹3,000 crore Durg capex progresses.
FCSSOFT Q2 Standalone Net Profit at ₹0.04 Cr vs ₹2.51 Cr Loss YoY; Revenue Rises to ₹9.12 Cr
FCS Software Solutions reported its Q2 FY27 (ended September 30, 2026) standalone financial results, showing a recovery to a net profit of ₹3.58 lakh (₹0.04 crore) compared to a net loss of ₹251.01 lakh (₹2.51 crore) in Q2 FY26. Standalone total revenue increased to ₹912.07 lakh (₹9.12 crore) from ₹818.62 lakh (₹8.19 crore) in the year-ago quarter. For H1 FY27, the company reported a standalone net profit of ₹71.31 lakh compared to a loss of ₹357.81 lakh in H1 FY26. Additionally, consolidated cash flows reflect a ₹36.42 crore cash outflow toward a share buyback in subsidiary Bloom Healthcare & Hospitality Management, reducing consolidated cash and cash equivalents to ₹14.03 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுFCS Software reported Q2 and H1 FY27 financial results, turning profitable on a standalone basis and accounting for a share buyback in subsidiary Bloom Healthcare.
ஏன் இது முக்கியம்The company has arrested operating losses at the standalone level, though revenue remains modest and profit margins are narrow on an annualized basis.
Standalone Q2 Revenue: ₹912.07 லட்சம்Standalone Q2 Net Profit: ₹3.58 லட்சம்Standalone H1 Net Profit: ₹71.31 லட்சம்Subsidiary Buyback Outflow: ₹3,641.63 லட்சம்
📅 குறுகிய காலம்Performance shows bottom-line stabilization compared to last year's losses, which may maintain neutral sentiment given the low absolute profit base.
📈 நீண்ட காலம்Limited; company needs substantial multi-quarter top-line expansion and sustained operating margins to structurally re-rate from current penny stock valuation.
⚠ அபாய எச்சரிக்கைகள்
Extremely thin absolute quarterly profit margin (net profit of ₹3.58 lakh on ₹9.12 crore revenue)
Significant cash depletion due to ₹36.42 crore buyback in subsidiary
👀 கவனிக்க வேண்டியவை
Track the sustainability of operating profit margins in upcoming quarters and monitor whether the subsidiary share buyback drives accretive consolidated returns.
Lenskart Q2 FY27 PAT Doubles to ₹232 Cr; Revenue Up 32.5% YoY to ₹2,845 Cr
Lenskart reported robust Q2 FY27 performance with revenue growing 32.5% YoY to ₹2,845 crore and profit after tax surging 106.1% YoY to ₹232 crore. EBITDA increased 46.6% YoY to ₹624 crore, expanding margins to 21.9%. Growth was supported by strong operational momentum, with India Same-Store Sales Growth (SSSG) at 20.8% and net addition of 165 stores in Q2 FY27 (reaching 3,624 total active stores). The company maintained a strong balance sheet with a cash balance of ₹3,855 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுLenskart published its Q2/H1 FY27 investor presentation detailing 30%+ revenue growth, margin expansion, and store expansion milestones.
ஏன் இது முக்கியம்Demonstrates operating leverage with PAT doubling, robust cash balances of ₹3,855 Cr, and solid execution in both domestic and international markets.
📅 குறுகிய காலம்Positive sentiment likely driven by 106% YoY PAT growth and 20.8% SSSG in the core India business.
📈 நீண்ட காலம்Vertical integration (manufacturing frames and lenses in-house) and store densification in India and overseas position the company on its target path toward a 25% EBITDA margin.
⚠ அபாய எச்சரிக்கைகள்
Execution risk across international scaling (Japan, Thailand, Saudi Arabia)
Potential cannibalization from rapid domestic store additions
👀 கவனிக்க வேண்டியவை
Track the sustainability of >20% SSSG in India and international EBITDA expansion, along with updates on the upcoming centralized manufacturing facility in Hyderabad.
Bliss GVS Pharma Secures UK MHRA Approval for Mesalazine 1g Suppositories
Bliss GVS Pharma Limited announced that its UK-based wholly owned subsidiary, Asterisk Lifesciences Ltd, has received Marketing Authorisation from the UK Medicines & Healthcare products Regulatory Agency (MHRA) for Mesalazine 1g Suppositories. The approval marks a key milestone in the company's strategy to expand into highly regulated western markets beyond its traditional semi-regulated African footprint (which historically drove ~93% of exports). Commercial launch timelines and targeted revenue potential were not disclosed in the filing.
உச்சம் நம்பிக்கை
என்ன மாறியதுBliss GVS Pharma's wholly owned UK arm obtained formal regulatory marketing approval from the UK MHRA for Mesalazine 1g Suppositories.
ஏன் இது முக்கியம்It supports the company's stated strategic objective to diversify revenue away from African semi-regulated markets into high-margin, regulated European markets.
📅 குறுகிய காலம்Sentimentally positive as it validates the company's regulatory compliance and niche suppository formulation capabilities in a tier-1 regulated market.
📈 நீண்ட காலம்Structurally positive step towards lowering geographical concentration risks from Africa and scaling regulated market formulations.
⚠ அபாய எச்சரிக்கைகள்
Commercialization and pricing details not disclosed
Execution risk regarding distribution partnerships in the UK market
👀 கவனிக்க வேண்டியவை
Track management commentary in upcoming earnings calls regarding the UK commercial rollout timeline, distribution tie-ups, and market size addressable by this product.
Univa Foods Posts Nil Q2 Revenue and Net Loss of ₹7.07 Lakhs; Net Worth Negative at ₹100.13 Lakhs
Univa Foods reported standalone financial results for Q2 FY27 (quarter ended September 30, 2026) with zero revenue from operations, flat compared to Q1 FY27. The company posted a net loss of ₹7.07 lakhs for the quarter compared to a loss of ₹4.61 lakhs in the preceding quarter. For the first half (H1 FY27), the cumulative net loss reached ₹11.68 lakhs on nil revenue. The company's balance sheet reflects acute distress with zero non-current assets and a negative total equity of ₹(100.13) lakhs against long-term borrowings of ₹110.49 lakhs.
உச்சம் நம்பிக்கை
என்ன மாறியதுUniva Foods reported its Q2 FY27 and H1 FY27 financial results, continuing to show zero revenue generation and an ongoing net operating loss.
ஏன் இது முக்கியம்The company continues to exhibit severe financial distress with no operational business activity, negative equity of ₹100.13 lakhs, and minimal liquid cash (₹0.60 lakhs) to cover liabilities.
📅 குறுகிய காலம்The lack of revenue and widening quarterly losses indicate ongoing operational dormancy, which is likely to keep sentiment depressed.
📈 நீண்ட காலம்With negative net worth, 0% promoter holding, and lack of fixed assets, the company faces significant going-concern risks unless an external revival or restructuring occurs.
⚠ அபாய எச்சரிக்கைகள்
Negative net worth of ₹(100.13) lakhs
Zero operating revenue and completely dormant operations
0% promoter shareholding
Cash balance down to just ₹0.60 lakhs against total debt of ₹110.49 lakhs
👀 கவனிக்க வேண்டியவை
Track whether management announces any operational revival plans, capital restructuring, or resolution for its negative net worth. Investors should also observe the auditor's going concern assessments in subsequent filings.
Q2 FY27 Net Profit at ₹8.56 Cr; Rs 375 Cr Shortfall in ICD Arbitration Contested at Delhi HC
Oswal Greentech reported standalone revenue from operations of ₹13.88 crore for Q2 FY27, up from ₹4.71 crore in Q1 FY27. Standalone net profit stood at ₹8.56 crore compared to ₹8.42 crore in the preceding quarter. The auditor highlighted an arbitration dispute regarding Inter Corporate Deposits (ICDs) where an award of ₹97.17 crore was passed against a total claim of ₹472.12 crore, creating a shortfall of ₹374.95 crore which the company is contesting in the Delhi High Court. Additionally, pending this litigation, unaccrued interest understated quarterly income and current assets by ₹10.71 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுOswal Greentech reported Q2 FY27 quarterly results and disclosed ongoing High Court litigation over an unfavorable ₹374.95 crore shortfall in an ICD arbitration award.
ஏன் இது முக்கியம்The ₹374.95 crore disputed ICD claim is significant relative to the company's market cap of ₹464 crore, meaning the outcome of the High Court appeal could materially impact asset recovery and cash flows.
Revenue from operations (Q2 FY27): ₹13.88 கோடிProfit for the period (Q2 FY27): ₹8.56 கோடிArbitration award received: ₹97.17 கோடிDisputed ICD claim shortfall: ₹374.95 கோடிShortfall vs Market Cap: ~80.8%Proposed Dubai Subsidiary Capitalization: AED 40 Million
📅 குறுகிய காலம்Operating performance improved quarter-on-quarter, but sentiment is likely to remain muted given auditor emphasis of matter regarding large ongoing ICD litigation.
📈 நீண்ட காலம்Recovery of pending ICDs and capital deployment into the AED 40 million Dubai entity and real estate projects will determine balance sheet liquidity and earnings stability.
⚠ அபாய எச்சரிக்கைகள்
Litigation risk: ₹374.95 crore shortfall in ICD arbitration challenged in Delhi High Court
Understatement of quarterly interest income by ₹10.71 crore due to contested interest
Capital deployment risk associated with AED 40 million overseas expansion
👀 கவனிக்க வேண்டியவை
Track the proceedings at the Delhi High Court concerning the ₹374.95 crore ICD arbitration shortfall, as well as operational progress on the AED 40 million Dubai subsidiary.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
